Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001350405 | SCV001544804 | uncertain significance | Wilson-Turner syndrome | 2020-07-08 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with methionine at codon 428 of the LAS1L protein (p.Val428Met). The valine residue is weakly conserved and there is a small physicochemical difference between valine and methionine. This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with LAS1L-related conditions. |
Revvity Omics, |
RCV001350405 | SCV003816486 | uncertain significance | Wilson-Turner syndrome | 2019-11-14 | criteria provided, single submitter | clinical testing | |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV004554857 | SCV005043827 | uncertain significance | not provided | 2024-02-07 | criteria provided, single submitter | clinical testing | PM2, BP4 |